Receive our newsletter – data, insights and analysis delivered to you
  1. News
March 24, 2021

Ro raises new capital to grow telehealth, in-home care capabilities

US healthcare technology company Ro has raised $500m in new capital to grow its vertically integrated primary care platform.

US healthcare technology company Ro has raised $500m in new capital to grow its vertically integrated primary care platform.

The Series D funding round was led by existing investors General Catalyst, FirstMark Capital and TQ Ventures along with existing investors SignalFire, Torch Capital and BoxGroup.

New investors that took part in the round are Altimeter Capital, Baupost Group, Dragoneer Investment Group, ShawSpring Partners, Radcliff, and 776.

Since 2017, when the company was founded, Ro has raised a total of $876m in funding.

The company intends to use the funds to build new capabilities and strengthen its existing abilities in telehealth services, pharmacy distribution, and in-home care delivery.

In addition, it will work on improving its proprietary EMR (the Ro Collaborative Care Center), and pharmacy distribution network.

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
The powerful networks advancing life sciences in Charleston | USA
The power of infrastructure: How Charleston | SC | USA is expanding horizons for life science companies

Ro co-founder and CEO Zachariah Reitano said: “Ro is the only company to combine a nationwide telemedicine, pharmacy distribution, and in-home care network.

“Through this vertically integrated platform we’re making high-quality care available when and where patients need it, with no insurance required so patients are the ones in control. We’re powering a patient revolution, and we’re just getting started.”

In December 2020, the company acquired Workpath software platform. This deal allowed Ro to integrate virtual and in-home care delivery on its vertically-integrated platform.

The company’s Covid-19 Vaccine Drive programme, which was recently introduced, is currently active in select Yonkers zip codes in New York.

Recently, it has also collaborated with healthcare AI company Gauss to provide the latter’s smartphone-powered, at-home Covid-19 rapid antigen tests on its platform.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU